Cargando…
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228472/ https://www.ncbi.nlm.nih.gov/pubmed/37260917 http://dx.doi.org/10.1097/HS9.0000000000000873 |
| _version_ | 1785050970851377152 |
|---|---|
| author | Lambert, Jérôme Di Blasi, Roberta Rabian, Florence Dourthe, Marie-Emilie Baruchel, André Thiéblemont, Catherine Boissel, Nicolas Levy, Vincent Picat, Marie-Quitterie Chevret, Sylvie |
| author_facet | Lambert, Jérôme Di Blasi, Roberta Rabian, Florence Dourthe, Marie-Emilie Baruchel, André Thiéblemont, Catherine Boissel, Nicolas Levy, Vincent Picat, Marie-Quitterie Chevret, Sylvie |
| author_sort | Lambert, Jérôme |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10228472 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102284722023-05-31 Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data Lambert, Jérôme Di Blasi, Roberta Rabian, Florence Dourthe, Marie-Emilie Baruchel, André Thiéblemont, Catherine Boissel, Nicolas Levy, Vincent Picat, Marie-Quitterie Chevret, Sylvie Hemasphere Letter Lippincott Williams & Wilkins 2023-05-29 /pmc/articles/PMC10228472/ /pubmed/37260917 http://dx.doi.org/10.1097/HS9.0000000000000873 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter Lambert, Jérôme Di Blasi, Roberta Rabian, Florence Dourthe, Marie-Emilie Baruchel, André Thiéblemont, Catherine Boissel, Nicolas Levy, Vincent Picat, Marie-Quitterie Chevret, Sylvie Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data |
| title | Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data |
| title_full | Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data |
| title_fullStr | Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data |
| title_full_unstemmed | Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data |
| title_short | Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data |
| title_sort | real-world experience of approved chimeric antigen receptor t-cell therapies compared to clinical trials data |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228472/ https://www.ncbi.nlm.nih.gov/pubmed/37260917 http://dx.doi.org/10.1097/HS9.0000000000000873 |
| work_keys_str_mv | AT lambertjerome realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT diblasiroberta realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT rabianflorence realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT dourthemarieemilie realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT baruchelandre realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT thieblemontcatherine realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT boisselnicolas realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT levyvincent realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT picatmariequitterie realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata AT chevretsylvie realworldexperienceofapprovedchimericantigenreceptortcelltherapiescomparedtoclinicaltrialsdata |